Back
Cardiff Oncology, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
35
CRDF
Cardiff Oncology, Inc.
Last Price:
$2.12
Seasonality Move:
11.94%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCardiff Oncology, Inc. Stock Forecast
-
Is Cardiff Oncology, Inc. Stock Undervalued?The current Cardiff Oncology, Inc. [CRDF] share price is $2.11. The Score for CRDF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
CRDF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Cardiff Oncology, Inc. Stock Go Up Next Year?
Data Unavailable
Cardiff Oncology, Inc. Stock Rating
Data Unavailable
Cardiff Oncology, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cardiffoncology.com
52-Week Data
52-Week High:
5.64
52-Week Low:
1.90
Prediction Charts
Market Cap:
142.1M
Price in USD:
2.11
Volume:
419.9K
Beta:
0.84
Technical Analysis
SMA50:
2.19
SMA100:
2.37
SMA200:
2.88
52-Wk Change:
-9.83%
Stock Predictions
-
Is Cardiff Oncology, Inc. stock public?Yes, Cardiff Oncology, Inc. is a publicly traded company.
-
What is the Cardiff Oncology, Inc. stock quote today?The Cardiff Oncology, Inc. stock price is 2.11 USD today.
-
How to buy Cardiff Oncology, Inc. stock online?You can buy Cardiff Oncology, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 2.10 | 2.06 | 2.17 | 2.04 |
| Nov-18 | 2.11 | 2.04 | 2.11 | 1.99 |
| Nov-19 | 2.02 | 2.00 | 2.06 | 1.96 |
| Nov-20 | 2.03 | 1.96 | 2.10 | 1.95 |
| Nov-21 | 1.96 | 2.03 | 2.04 | 1.90 |
| Nov-24 | 2.03 | 2.08 | 2.11 | 2.03 |
| Nov-25 | 2.10 | 2.11 | 2.12 | 2.07 |
| Nov-26 | 2.10 | 2.34 | 2.37 | 2.09 |
| Nov-28 | 2.34 | 2.28 | 2.34 | 2.25 |
| Dec-1 | 2.26 | 2.17 | 2.26 | 2.16 |
| Dec-2 | 2.17 | 2.04 | 2.19 | 2.04 |
| Dec-3 | 2.05 | 2.13 | 2.15 | 2.03 |
| Dec-4 | 2.11 | 2.16 | 2.20 | 2.10 |
| Dec-5 | 2.17 | 2.11 | 2.21 | 2.09 |
Cardiff Oncology, Inc. Earnings
Data Unavailable
Cardiff Oncology, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.02 per share.
* Cardiff Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.